Gregory C. Flaker

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

Stuart J. Connolly, Janice Pogue, John W. Eikelboom et al. · Circulation · 2008 · 873 citations · Full text

Medicine, Cardiology, Pharmacology +14

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

John Dimarco, Gregory C. Flaker, Albert L. Waldo et al. · American Heart Journal · 2005 · 217 citations

Medicine, Cardiology, Pharmacotherapy +17

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

Sana M. Al‐Khatib, Laine Thomas, Lars Wallentin et al. · European Heart Journal · 2013 · 192 citations · Full text

Medicine, Cardiology, Pharmacology +9

<i>Helicobacter pylori</i> Infection Impairs Endothelial Function Through an Exosome‐Mediated Mechanism

Xiujuan Xia, Linfang Zhang, Jingshu Chi et al. · Journal of the American Heart Association · 2020 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION - AN ANALYSIS OF PATIENTS UNDERGOING CARDIOVERSION

Meghashyam J. Koti, Amit Parekh, Stuart J. Connolly et al. · Journal of the American College of Cardiology · 2010 · 57 citations

Medicine, Cardiology, Pharmacology +10